This two-part series is hosted by Dr. Michael McClung, the Founding Director of the Oregon Osteoporosis Center in Portland and an internationally recognized clinician, researcher, and educator in osteoporosis and metabolic bone diseases. Throughout these episodes, he will speak with two pioneers in the osteoporosis treatment field, Socrates Papapoulos and Felicia Cosman.  These ASBMR members have been critical in harnessing the genetics of high bone mass disorders for their translation into...

This two-part series is hosted by Dr. Michael McClung, the Founding Director of the Oregon Osteoporosis Center in Portland and an internationally recognized clinician, researcher, and educator in osteoporosis and metabolic bone diseases. Throughout these episodes, he will speak with two pioneers in the osteoporosis treatment field, Socrates Papapoulos and Felicia Cosman.  These ASBMR members have been critical in harnessing the genetics of high bone mass disorders for their translation into a...

Our latest series is hosted by Dr. Dolores Shoback, Professor of Medicine at the University of California, San Francisco. Throughout this four part series, we’ll speak with pioneers in the PTH field. We’ll explore basic PTH physiology, actions of PTHrP, PTH for Osteoporosis Treatment and Hypoparathyroidism. The fourth and final episode of this series features Dr. John Bilezikian, Silberberg Professor of Medicine at the Vagelos College of Physicians and Surgeons at Columbia University. John...

Our latest series is hosted by Dr. Dolores Shoback, Professor of Medicine at the University of California, San Francisco. Throughout this four part series, we’ll speak with pioneers in the PTH field. We’ll explore basic PTH physiology, actions of PTHrP, PTH for Osteoporosis Treatment and Hypoparathyroidism. Episode three features Dr. Benjamin Leder, Professor of Medicine at Harvard University located at Massachusetts General Hospital. Leder shares his beginnings in the field, his experience...

Our latest series is hosted by Dr. Dolores Shoback, Professor of Medicine at the University of California, San Francisco. Throughout this four part series, we’ll speak with pioneers in the PTH field. We’ll explore basic PTH physiology, actions of PTHrP, PTH for Osteoporosis Treatment and Hypoparathyroidism. Episode two features guest Dr. Natalie Sims, Deputy Director of St. Vincent's Institute in Melbourne, Australia and Professorial Fellow at University of Melbourne. In this episode, we'll...

Our latest series is hosted by Dr. Dolores Shoback, Professor of Medicine at the University of California, San Francisco. Throughout this four part series, we’ll speak with pioneers in the PTH field. We’ll explore basic PTH physiology, actions of PTHrP, PTH for Osteoporosis Treatment and Hypoparathyroidism. Episode one features guest Dr. Hank Kronenberg, Endocrinologist at Massachusetts General Hospital and Harvard Medical School. In this episode, we'll dive into his beginnings in the field,...

Our initial series, Pathways: ASBMR Stories of Discovery, is hosted by Dr. Michael Econs, Distinguished Professor at the Indiana University School of Medicine. Throughout this three part series, we speak with pioneers in discovery of FGF23. We explore dysregulation of FGF23 in renal failure, inhibiting FGF23 for treatment of XLH, and the interplay of FGF23 and iron. Episode three features Dr. Myles Wolf—Professor of Medicine and Chief of Nephrology at Duke University—on the link between iron...

Our initial series, Pathways: ASBMR Stories of Discovery, is hosted by Dr. Michael Econs, Distinguished Professor at the Indiana University School of Medicine. Throughout this three part series, we speak with pioneers in discovery of FGF23. We explore dysregulation of FGF23 in renal failure, inhibiting FGF23 for treatment of XLH, and the interplay of FGF23 and iron. Episode two features Dr. Kenneth White—Professor of Medical and Molecular Genetics at Indiana University—on his journey through...

Our initial series, Pathways: ASBMR Stories of Discovery, is hosted by Dr. Michael Econs, Distinguished Professor at the Indiana University School of Medicine. Throughout this three part series, we speak with pioneers in discovery of FGF23. We explore dysregulation of FGF23 in renal failure, inhibiting FGF23 for treatment of XLH, and the interplay of FGF23 and iron. Episode one features a X-linked Hypophosphatemia-focused discussion with Dr. Thomas Carpenter. Dr. Carpenter has maintained a...